RIoT offers their annual, bi-partisan, collaborative State of the Region address to highlight opportunities and growth across the State of North Carolina.

Annexin Pharmaceuticals AB today announces favourable findings in the company's ongoing Proof of Concept Phase 2a study with the drug candidate ANXV in Diabetic Retinopathy (DR) and Retinal Vein Occlu ...